Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma.

Peng WangSong YangShengbin DaiQingtao NiHuilan LiuLei YuKaijin LuGaohua HanJunxing Huang

Published in: OncoTargets and therapy (2021)

Our results suggest that LncRNA GAPLINC may be used as a biomarker for the diagnosis and monitoring of ESCC, and may play an oncogenic role in ESCC.

Keyphrases